IPO · ALMR
Alamar Biosciences, Inc.
Alamar Biosciences, Inc. (ALMR) priced its initial public offering on Apr 17, 2026 at $17.00 per share, within its $15.00–$17.00 range, raising $191.2M, and listed on Nasdaq Global Select. At the IPO price its market capitalization was about $1.13B. Latham & Watkins advised the underwriters.
- Status
- IPO
- Ticker
- ALMR
- Exchange
- Nasdaq Global Select
- Priced
- Apr 17, 2026
- IPO price
- $17.00
- Price range
- $15.00–$17.00
- Raised
- $191.2M
- Market cap at IPO price
- $1.13B
- First filed
- Mar 27, 2026
- Underwriters' counsel
- Latham & Watkins
- Sector
- Industrials & materials
- Country / state
- CA
Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.
More on this listing for subscribers
- Lock-up period and expiry date
- Shares offered, over-allotment and shares outstanding after the offering
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Registration statement (S-1) first filed Mar 27, 2026
- Latest amendment Apr 16, 2026
- Final prospectus (424B4) Apr 17, 2026
- All filings on EDGAR CIK 2104204
Other Industrials & materials IPOs in 2026
- X-Energy, Inc.XE · Apr 27, 2026 · $1.02B
- Elmet Group Co.ELMT · Apr 23, 2026 · $120M
- Liberty Defense Holdings, Ltd.DETX · Apr 21, 2026
- AEVEX Corp.AVEX · Apr 20, 2026 · $320M
- Madison Air Solutions CorpMAIR · Apr 17, 2026 · $2.23B
- Arxis, Inc.ARXS · Apr 16, 2026 · $1.13B